首页> 外文期刊>The Lancet >Inhaled corticosteroids and asthma prevention.
【24h】

Inhaled corticosteroids and asthma prevention.

机译:吸入糖皮质激素和预防哮喘。

获取原文
获取原文并翻译 | 示例
           

摘要

In today's Lancet, Clare Murray and colleagues1 report a trial that tested the hypothesis that inhaled corticosteroids, when administered to symptomatic preschool children, can change the natural course of asthma. There was no difference between drug and placebo. Two other similar trials (PEAK and PAC), which failed to show a difference, were recently published.It is useful first to define what is meant by the natural course of asthma. There ought to be a first period during which there is no clinical evidence of the disease, and during this phase factors that determine inception are at work. At inception, which could be identified with the first manifestations of the disease, two scenarios are possible: either the physiological and anatomical features, congenital or acquired, that underlie the subsequent chronic expression of the disease are already present (course A-C, figure), or they are not (B-D), and develop concomitantly with the transition between initial phase and full-blown chronic illness. Remission (B-E) is also possible and is common in young children, the so-called transient wheezers.
机译:在今天的《柳叶刀》杂志上,克莱尔·默里(Clare Murray)及其同事1报告了一项试验,该试验检验了对有症状的学龄前儿童吸入皮质类固醇可改变哮喘自然病程的假设。药物和安慰剂之间没有区别。最近还发表了另外两项类似的试验(PEAK和PAC),但均未显示出差异,这首先有助于确定哮喘的自然病程。应该有一个第一阶段,在此期间没有该疾病的临床证据,并且在此阶段,确定开始的因素正在起作用。在开始时,可​​以用疾病的最初表现来识别,可能出现两种情况:先天性或后天性的生理和解剖特征,这些特征是随后疾病的慢性表达的基础(过程AC,图),或者它们不是(BD),并且随着初始阶段和成熟的慢性疾病之间的过渡而发展。缓解(B-E)也是可能的,并且常见于幼儿,即所谓的短暂喘息者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号